Gufic Biosciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Individual Investor
Equibles does not estimate personal net worth.
Agam Shah is recorded as Analyst at Individual Investor. Agam Shah has spoken on 3 earnings calls across 3 companies, most recently for Gufic Biosciences Limited on August 17, 2026. Those appearances were for Gufic Biosciences Limited, Latent View Analytics Limited and Concord Enviro Systems Limited. The companies whose calls Agam Shah spoke on are classified in the Healthcare, Industrials and Utilities sectors.
“One, if you can, you know, maybe it's still early, but yet you can elaborate. On the Botox and Tire, which we did last quarter, the Canada Fillers thing, how can it scale up this year in terms of revenue and going ahead?”
“So, on a comment on the opening remarks, you mentioned that there was some softness in terms of pricing from a few of your customers, if I am correct. Elaborate on that.”
“In one of your slides, it says that the TCV order book is 800 crores and total average order value is 536 crores. So what is the order book?”
Individual Investor
Analyst
Transcript header (unverified)
Gufic Biosciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Latent View Analytics Limited
Consulting Services · Industrials
Concord Enviro Systems Limited
Utilities - Regulated Water · Utilities
Earnings Call
Gufic Biosciences Limited
Earnings Call for the Quarter Ended June 30, 2026
Latent View Analytics Limited
Earnings Call for the Quarter Ended March 31, 2026
Concord Enviro Systems Limited